biote Corp. (BTMD)Healthcare | Medical Care Facilities | Irving, United States | NasdaqGM
1.57 USD
-0.06
(-3.681%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 1.57 |
Hot Take ↕ | Aug. 22, 2026, 3:55 a.m. EDT
The immediate outlook is severely clouded by a brutal recent price collapse. Despite a recent earnings beat on EPS, the company missed revenue estimates, triggering a sharp sell-off where the stock plunged from $2.27 to $1.30 within a single week, erasing nearly half its value in days. This volatility, combined with a trailing PE of 10.7x and a forward PE of 3.6x, suggests the market is aggressively pricing out future uncertainty rather than valuing current earnings. The balance sheet is fragile, with total debt of $128.6 million dwarfing cash reserves of only $11.2 million, creating a precarious liquidity situation for a firm generating negative free cash flow. While the forward P/E implies analysts expect significant earnings recovery, the structural debt load and recent operational miss make this a high-risk speculative play rather than a sound investment. There is absolutely no income component here, as the company has not paid a dividend in five years, offering no cushion against further downside. The statistical forecasting models are useless given their extremely low reliability scores, confirming that short-term price movements are currently driven by noise and panic rather than predictable trends. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.154526 |
| AutoETS | 0.157863 |
| AutoTheta | 0.161116 |
| MSTL | 0.162069 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 28% |
| H-stat | 10.83 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.053 |
| Excess Kurtosis | -0.95 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 6.053 |
| Market Cap | 53,221,808 |
| Trailing P/E | 12.08 |
| Forward P/E | 3.49 |
| Beta | 1.65 |
| Profit Margins | 3.19% |
| Website | https://www.biote.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.52478135 |
| Address1 | 1,875 W. Walnut Hill Ln #100 |
| All Time High | 10.525 |
| All Time Low | 1.27 |
| Ask | 2.9 |
| Ask Size | 2 |
| Audit Risk | 10 |
| Average Analyst Rating | 1.4 - Strong Buy |
| Average Daily Volume10 Day | 422,340 |
| Average Daily Volume3 Month | 314,916 |
| Average Volume | 314,916 |
| Average Volume10Days | 422,340 |
| Beta | 1.646 |
| Bid | 1.62 |
| Bid Size | 2 |
| Board Risk | 8 |
| Book Value | -2.378 |
| City | Irving |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 9 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.57 |
| Current Ratio | 1.43 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 1.69 |
| Day Low | 1.57 |
| Display Name | biote |
| Earnings Call Timestamp End | 1,785,963,600 |
| Earnings Call Timestamp Start | 1,785,963,600 |
| Earnings Timestamp | 1,785,960,000 |
| Earnings Timestamp End | 1,793,822,400 |
| Earnings Timestamp Start | 1,793,822,400 |
| Ebitda | 25,484,000 |
| Ebitda Margins | 0.13885 |
| Enterprise To Ebitda | 6.675 |
| Enterprise To Revenue | 0.927 |
| Enterprise Value | 170,093,808 |
| Eps Current Year | 0.35 |
| Eps Forward | 0.45 |
| Eps Trailing Twelve Months | 0.13 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.984 |
| Fifty Day Average Change | -0.41399992 |
| Fifty Day Average Change Percent | -0.20866932 |
| Fifty Two Week Change Percent | -52.478134 |
| Fifty Two Week High | 3.62 |
| Fifty Two Week High Change | -2.0499997 |
| Fifty Two Week High Change Percent | -0.5662983 |
| Fifty Two Week Low | 1.27 |
| Fifty Two Week Low Change | 0.30000007 |
| Fifty Two Week Low Change Percent | 0.23622054 |
| Fifty Two Week Range | 1.27 - 3.62 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,619,616,600,000 |
| Float Shares | 18,869,567 |
| Forward Eps | 0.45 |
| Forward P E | 3.488889 |
| Free Cashflow | -4,994,625 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 223 |
| Fullday Change | -0.0599999 |
| Fullday Change Percent | -3.68098 |
| Fullday Price | 1.57 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,785,542,400 |
| Gross Margins | 0.69449997 |
| Gross Profits | 127,462,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.11447 |
| Held Percent Institutions | 0.63055 |
| Implied Shares Outstanding | 33,899,242 |
| Industry | Medical Care Facilities |
| Industry Disp | Medical Care Facilities |
| Industry Key | medical-care-facilities |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to facilitate ordering and inventory control; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female patients. The company was founded in 2012 and is headquartered in Irving, Texas. |
| Long Name | biote Corp. |
| Market | us_market |
| Market Cap | 53,221,808 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_1761348473 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | 5,856,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 47,461,409 |
| Number Of Analyst Opinions | 5 |
| Open | 1.63 |
| Operating Cashflow | 24,367,000 |
| Operating Margins | 0.0529 |
| Overall Risk | 9 |
| Payout Ratio | 0.0 |
| Phone | 844 604 1246 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 1.57 |
| Post Market Time | 1,787,959,806 |
| Previous Close | 1.63 |
| Price Eps Current Year | 4.4857144 |
| Price Hint | 4 |
| Price To Book | -0.6602187 |
| Price To Sales Trailing12 Months | 0.2899881 |
| Profit Margins | 0.03191 |
| Quick Ratio | 0.69 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.4 |
| Region | US |
| Regular Market Change | -0.0599999 |
| Regular Market Change Percent | -3.68098 |
| Regular Market Day High | 1.69 |
| Regular Market Day Low | 1.57 |
| Regular Market Day Range | 1.57 - 1.69 |
| Regular Market Open | 1.63 |
| Regular Market Previous Close | 1.63 |
| Regular Market Price | 1.57 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 141,918 |
| Return On Assets | 0.13704 |
| Revenue Growth | -0.095 |
| Revenue Per Share | 6.053 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 6 |
| Shares Outstanding | 28,677,589 |
| Shares Percent Shares Out | 0.023 |
| Shares Short | 658,978 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 578,682 |
| Short Name | Biote Corp. |
| Short Percent Of Float | 0.0324 |
| Short Ratio | 3.06 |
| Source Interval | 15 |
| State | TX |
| Symbol | BTMD |
| Target High Price | 4.0 |
| Target Low Price | 1.5 |
| Target Mean Price | 2.612 |
| Target Median Price | 2.5 |
| Total Cash | 11,168,000 |
| Total Cash Per Share | 0.389 |
| Total Debt | 128,640,000 |
| Total Revenue | 183,531,008 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 0.13 |
| Trailing P E | 12.076924 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 2.127425 |
| Two Hundred Day Average Change | -0.5574249 |
| Two Hundred Day Average Change Percent | -0.2620186 |
| Type Disp | Equity |
| Volume | 141,918 |
| Website | https://www.biote.com |
| Zip | 75,038 |